Gery P Guy1, Zahava Berkowitz2, Donatus U Ekwueme2, Sun Hee Rim2, K Robin Yabroff3. 1. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; and irm2@cdc.gov. 2. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; and. 3. Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.
Abstract
BACKGROUND AND OBJECTIVES: Although adult survivors of childhood cancers have poorer health and greater health limitations than other adults, substantial gaps remain in understanding the economic consequences of surviving childhood cancer. Therefore, we estimated the economic burden of productivity losses among adult survivors of childhood cancers. METHODS: We examined health status, functional limitations, and productivity loss among adult survivors of childhood cancers (n = 239) diagnosed at ≤14 years of age compared with adults without a history of cancer (n = 304 265) by using the 2004-2014 National Health Interview Survey. We estimated economic burden using the productivity loss from health-related unemployment, missed work days, missed household productivity, and multivariable regression models controlling for age, sex, race/ethnicity, education, comorbidities, and survey year. RESULTS: Childhood cancer survivorship is associated with a substantial economic burden. Adult survivors of childhood cancers are more likely to be in poorer health, need assistance with personal care and routine needs, have work limitations, be unable to work because of health, miss more days of work, and have greater household productivity loss compared with adults without a history of cancer (all P < .05). The annual productivity loss for adult survivors of childhood cancer is $8169 per person compared with $3083 per person for individuals without a history of cancer. CONCLUSIONS: These findings underscore the importance of efforts to reduce the health and economic burden among adult survivors of childhood cancer. In addition, this study highlights the potential productivity losses that could be avoided during adulthood from the prevention of childhood cancer in the United States.
BACKGROUND AND OBJECTIVES: Although adult survivors of childhood cancers have poorer health and greater health limitations than other adults, substantial gaps remain in understanding the economic consequences of surviving childhood cancer. Therefore, we estimated the economic burden of productivity losses among adult survivors of childhood cancers. METHODS: We examined health status, functional limitations, and productivity loss among adult survivors of childhood cancers (n = 239) diagnosed at ≤14 years of age compared with adults without a history of cancer (n = 304 265) by using the 2004-2014 National Health Interview Survey. We estimated economic burden using the productivity loss from health-related unemployment, missed work days, missed household productivity, and multivariable regression models controlling for age, sex, race/ethnicity, education, comorbidities, and survey year. RESULTS:Childhood cancer survivorship is associated with a substantial economic burden. Adult survivors of childhood cancers are more likely to be in poorer health, need assistance with personal care and routine needs, have work limitations, be unable to work because of health, miss more days of work, and have greater household productivity loss compared with adults without a history of cancer (all P < .05). The annual productivity loss for adult survivors of childhood cancer is $8169 per person compared with $3083 per person for individuals without a history of cancer. CONCLUSIONS: These findings underscore the importance of efforts to reduce the health and economic burden among adult survivors of childhood cancer. In addition, this study highlights the potential productivity losses that could be avoided during adulthood from the prevention of childhood cancer in the United States.
Authors: David Strauser; James L Klosky; Tara M Brinkman; Alex W K Wong; Fong Chan; Jennifer Lanctot; Rohit P Ojha; Leslie L Robison; Melissa M Hudson; Kirsten K Ness Journal: J Cancer Surviv Date: 2014-07-22 Impact factor: 4.442
Authors: Siobhan M Phillips; Lynne S Padgett; Wendy M Leisenring; Kayla K Stratton; Ken Bishop; Kevin R Krull; Catherine M Alfano; Todd M Gibson; Janet S de Moor; Danielle Blanch Hartigan; Gregory T Armstrong; Leslie L Robison; Julia H Rowland; Kevin C Oeffinger; Angela B Mariotto Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-04 Impact factor: 4.254
Authors: Anne C Kirchhoff; Wendy Leisenring; Kevin R Krull; Kirsten K Ness; Debra L Friedman; Gregory T Armstrong; Marilyn Stovall; Elyse R Park; Kevin C Oeffinger; Melissa M Hudson; Leslie L Robison; Thomas Wickizer Journal: Med Care Date: 2010-11 Impact factor: 2.983
Authors: Paul C Nathan; Jennifer S Ford; Tara O Henderson; Melissa M Hudson; Karen M Emmons; Jacqueline N Casillas; E Anne Lown; Kirsten K Ness; Kevin C Oeffinger Journal: J Clin Oncol Date: 2009-03-02 Impact factor: 44.544
Authors: Elyse R Park; Frederick P Li; Yan Liu; Karen M Emmons; Arthur Ablin; Leslie L Robison; Ann C Mertens Journal: J Clin Oncol Date: 2005-12-20 Impact factor: 50.717
Authors: Deborah B Crom; Kirsten K Ness; Larry R Martinez; Michelle R Hebl; Leslie L Robison; Melissa M Hudson; Tara M Brinkman Journal: J Cancer Surviv Date: 2018-03-17 Impact factor: 4.442
Authors: I-Chan Huang; Nickhill Bhakta; Tara M Brinkman; James L Klosky; Kevin R Krull; DeoKumar Srivastava; Melissa M Hudson; Leslie L Robison Journal: J Natl Cancer Inst Date: 2019-02-01 Impact factor: 13.506
Authors: Janet S de Moor; Catherine M Alfano; Erin E Kent; Wynne E Norton; Diarmuid Coughlan; Megan C Roberts; Melvin Grimes; Cathy J Bradley Journal: J Natl Cancer Inst Date: 2018-10-01 Impact factor: 13.506
Authors: Amy D Lu; Zhiyuan Zheng; Xuesong Han; Ruowen Qi; Jingxuan Zhao; K Robin Yabroff; Paul C Nathan Journal: J Natl Cancer Inst Date: 2021-08-02 Impact factor: 11.816
Authors: Angela B Mariotto; Lindsey Enewold; Jingxuan Zhao; Christopher A Zeruto; K Robin Yabroff Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-06-10 Impact factor: 4.090
Authors: Wonjeong Chae; Juyeong Kim; Sohee Park; Eun-Cheol Park; Sung-In Jang Journal: Int J Environ Res Public Health Date: 2020-08-19 Impact factor: 3.390
Authors: Nicolas Waespe; Sven Strebel; Tiago Nava; Chakradhara Rao S Uppugunduri; Denis Marino; Veneranda Mattiello; Maria Otth; Fabienne Gumy-Pause; André O Von Bueren; Frederic Baleydier; Luzius Mader; Adrian Spoerri; Claudia E Kuehni; Marc Ansari Journal: BMJ Open Date: 2022-01-24 Impact factor: 2.692
Authors: Katie A Devine; Salome Christen; Renée L Mulder; Morven C Brown; Lisa M Ingerski; Luzius Mader; Emma J Potter; Charlotte Sleurs; Adrienne S Viola; Susanna Waern; Louis S Constine; Melissa M Hudson; Leontien C M Kremer; Roderick Skinner; Gisela Michel; Jordan Gilleland Marchak; Fiona S M Schulte Journal: Cancer Date: 2022-04-18 Impact factor: 6.921